
|Articles|August 1, 2002
Excimer laser treatment now approved for irregular astigmatism
Philadelphia-Excimer laser treatment using the Custom Cap (VISX, Sunnyvale, CA) method seems to be a promising therapeutic approach for reducing optical aberrations in eyes with less than satisfactory visual outcomes after refractive surgery.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD
2
Avisi Technologies treats first patient in SAPPHIRE trial for glaucoma
3
FDA approves Amneal Pharmaceuticals' cyclosporine ophthalmic emulsion 0.05%
4
Eydenzelt, Celltrion’s biosimilar referencing Eylea, approved in Canada
5















































.png)


